Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells
Author:
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
https://link.springer.com/content/pdf/10.1007/s12079-023-00756-9.pdf
Reference36 articles.
1. Ahmad A (2013) Pathways to breast cancer recurrence. ISRN Oncol 2013:290568. https://doi.org/10.1155/2013/290568
2. Ayob AZ, Ramasamy TS (2018) Cancer stem cells as key drivers of tumour progression. J Biomed Sci 25:20. https://doi.org/10.1186/s12929-018-0426-4
3. Bouattour M, Raymond E, Qin S et al (2018) Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma. Hepatology 67:1132–1149. https://doi.org/10.1002/hep.29496
4. Chatterjee S, Kundu CN (2020) Nanoformulated quinacrine regulates NECTIN-4 domain specific functions in cervical cancer stem cells. Eur J Pharmacol 883:173308. https://doi.org/10.1016/j.ejphar.2020.173308
5. Chatterjee S, Sinha S, Molla S et al (2021) PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: role of nitric oxide (NO). Cell Signal 80:109902. https://doi.org/10.1016/j.cellsig.2020.109902
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment;Cancer Treatment Reviews;2024-06
2. Near Infrared-Responsive Quinacrine–Gold Hybrid Nanoparticles Deregulate HSP-70/P300-Mediated H3K14 Acetylation in ER/PR+ Breast Cancer Stem Cells;Nanomedicine;2024-03
3. Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agents;RSC Medicinal Chemistry;2024
4. Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells;Expert Opinion on Therapeutic Targets;2023-10-03
5. Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells;Phytomedicine;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3